Lung diffusing capacity in adult bronchiectasis: A longitudinal study

Paul King, Stephen Holdsworth, Nick Freezer, Elmer Virgil Villanueva, Michael Farmer, Paul Guy, Peter Holmes

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

Recent studies described a progressive decline in lung volumes in adult bronchiectasis. Interstitial lung disease is also a feature of bronchiectasis, but whether this is associated with a decline in lung diffusing capacity (measured as the diffusing capacity of the lung for carbon monoxide [D(LCO)]) is not well known. OBJECTIVE: To assess longitudinal decline in diffusing capacity of the lung for carbon monoxide (D(LCO)) in adult bronchiectasis. METHODS: Sixty-one subjects had a detailed baseline clinical and laboratory assessment, then were followed regularly with clinical and lung-function assessment for a median 7 years.
Original languageEnglish
Pages (from-to)1686 - 1692
Number of pages7
JournalRespiratory care
Volume55
Issue number12
Publication statusPublished - 2010

Cite this

King, Paul ; Holdsworth, Stephen ; Freezer, Nick ; Villanueva, Elmer Virgil ; Farmer, Michael ; Guy, Paul ; Holmes, Peter. / Lung diffusing capacity in adult bronchiectasis: A longitudinal study. In: Respiratory care. 2010 ; Vol. 55, No. 12. pp. 1686 - 1692.
@article{e1e20f008b804e7c8375fd358456d628,
title = "Lung diffusing capacity in adult bronchiectasis: A longitudinal study",
abstract = "Recent studies described a progressive decline in lung volumes in adult bronchiectasis. Interstitial lung disease is also a feature of bronchiectasis, but whether this is associated with a decline in lung diffusing capacity (measured as the diffusing capacity of the lung for carbon monoxide [D(LCO)]) is not well known. OBJECTIVE: To assess longitudinal decline in diffusing capacity of the lung for carbon monoxide (D(LCO)) in adult bronchiectasis. METHODS: Sixty-one subjects had a detailed baseline clinical and laboratory assessment, then were followed regularly with clinical and lung-function assessment for a median 7 years.",
author = "Paul King and Stephen Holdsworth and Nick Freezer and Villanueva, {Elmer Virgil} and Michael Farmer and Paul Guy and Peter Holmes",
year = "2010",
language = "English",
volume = "55",
pages = "1686 -- 1692",
journal = "Respiratory care",
issn = "0020-1324",
number = "12",

}

Lung diffusing capacity in adult bronchiectasis: A longitudinal study. / King, Paul; Holdsworth, Stephen; Freezer, Nick; Villanueva, Elmer Virgil; Farmer, Michael; Guy, Paul; Holmes, Peter.

In: Respiratory care, Vol. 55, No. 12, 2010, p. 1686 - 1692.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Lung diffusing capacity in adult bronchiectasis: A longitudinal study

AU - King, Paul

AU - Holdsworth, Stephen

AU - Freezer, Nick

AU - Villanueva, Elmer Virgil

AU - Farmer, Michael

AU - Guy, Paul

AU - Holmes, Peter

PY - 2010

Y1 - 2010

N2 - Recent studies described a progressive decline in lung volumes in adult bronchiectasis. Interstitial lung disease is also a feature of bronchiectasis, but whether this is associated with a decline in lung diffusing capacity (measured as the diffusing capacity of the lung for carbon monoxide [D(LCO)]) is not well known. OBJECTIVE: To assess longitudinal decline in diffusing capacity of the lung for carbon monoxide (D(LCO)) in adult bronchiectasis. METHODS: Sixty-one subjects had a detailed baseline clinical and laboratory assessment, then were followed regularly with clinical and lung-function assessment for a median 7 years.

AB - Recent studies described a progressive decline in lung volumes in adult bronchiectasis. Interstitial lung disease is also a feature of bronchiectasis, but whether this is associated with a decline in lung diffusing capacity (measured as the diffusing capacity of the lung for carbon monoxide [D(LCO)]) is not well known. OBJECTIVE: To assess longitudinal decline in diffusing capacity of the lung for carbon monoxide (D(LCO)) in adult bronchiectasis. METHODS: Sixty-one subjects had a detailed baseline clinical and laboratory assessment, then were followed regularly with clinical and lung-function assessment for a median 7 years.

M3 - Article

VL - 55

SP - 1686

EP - 1692

JO - Respiratory care

JF - Respiratory care

SN - 0020-1324

IS - 12

ER -